Antiretroviral Drugs
Electronic Monitoring of Oral Therapies in Ethnically Diverse and Economically Disadvantaged Patients With Rheumatoid Arthritis: Consequences of Low Adherence.
Electronic Monitoring of Oral Therapies in Ethnically Diverse and Economically Disadvantaged Patients With Rheumatoid Arthritis: Consequences of Low Adherence.
Arthritis Rheum. 2013 Jun; 65(6): 1421-1429
Waimann CA, Marengo MF, de Achaval S, Cox VL, Garcia-Gonzalez A, Reveille JD, Richardson… Continue reading →
Therapeutic Options in Docetaxel-Refractory Metastatic Castration-Resistant Prostate Cancer: A Cost-Effectiveness Analysis.
Therapeutic options in docetaxel-refractory metastatic castration-resistant prostate cancer: a cost-effectiveness analysis.
PLoS One. 2013; 8(5): e64275
Zhong L, Pon V, Srinivas S, Nguyen N, Frear M, Kwon S, Gong C, Malmstrom R, Wilson L
Docetaxel is an established first-line… Continue reading →
Treatment of Chronic Hepatitis C Infection Among Current and Former Injection Drug Users Within a Multidisciplinary Treatment Model at a Community Health Centre.
Treatment of chronic hepatitis C infection among current and former injection drug users within a multidisciplinary treatment model at a community health centre.
Can J Gastroenterol. 2013 Apr; 27(4): 217-23
Newman AI, Beckstead S, Beking D, Finch S, Knorr… Continue reading →
Successful Use of Cyclophosphamide as an Add-on Therapy for Multiple Myeloma Patients With Acquired Resistance to Bortezomib or Lenalidomide.
Successful use of cyclophosphamide as an add-on therapy for multiple myeloma patients with acquired resistance to bortezomib or lenalidomide.
Case Rep Hematol. 2013; 2013: 651902
Ito S, Oyake T, Murai K, Ishida Y
Novel agents such as thalidomide, lenalidomide,… Continue reading →
Human rElafin Inhibits HIV-1 Replication in Its Natural Target Cells.
Human rElafin Inhibits HIV-1 Replication in Its Natural Target Cells.
Biores Open Access. 2013 Apr; 2(2): 128-137
Jasinghe VJ, Peyrotte EA, Meyers AF, Gajanayaka N, Ball TB, Sandstrom P, Lavigne C
Trappin-2/elafin is a novel innate immune factor that… Continue reading →
Population Pharmacokinetic Analysis of a Nevirapine-Based HIV-1 Prevention of Mother-to-Child Transmission Program in Uganda to Assess the Impact of Different Dosing Regimens for Newborns.
Population Pharmacokinetic Analysis of a Nevirapine-Based HIV-1 Prevention of Mother-to-Child Transmission Program in Uganda to Assess the Impact of Different Dosing Regimens for Newborns.
J Clin Pharmacol. 2013 Mar; 53(3): 294-304
Frank M, Harms G, Kunz A, Kloft C… Continue reading →
Drug and Alcohol Rehabilitation: Non-Invasive Imaging of Phosphoinositide-3-Kinase-Catalytic-Subunit-Alpha (PIK3CA) Promoter Modulation in Small Animal Models.
Non-Invasive Imaging of Phosphoinositide-3-Kinase-Catalytic-Subunit-Alpha (PIK3CA) Promoter Modulation in Small Animal Models.
Filed under: Drug and Alcohol Rehabilitation
PLoS One. 2013; 8(2): e55971
Gaikwad SM, Gunjal L, Junutula AR, Astanehe A, Gambhir SS, Ray P
Activation of the PI3K/Akt pathway,… Continue reading →
Easy Quantitative Methodology to Assess Visual-Motor Skills.
Easy quantitative methodology to assess visual-motor skills.
Filed under: Rehab Centers
Neuropsychiatr Dis Treat. 2013; 9: 93-100
Chiappedi M, Toraldo A, Mandrini S, Scarpina F, Aquino M, Magnani FG, Bejor M
Visual-motor skills are the basis for a great… Continue reading →
Depression & Anxiety.Cures for Depression.Anxiety Definition.Remedies for Anxiety
Depression & Anxiety.Cures For Depression.Anxiety Definition.Remedies For Anxiety – free-review-tips.info ,Depression & Anxiety.cures for depression.anxiety definition.remedies for anxiety.,bipolar treatment,social anxiety,cures for depression,anxiety definition,remedies for anxiety,anxiety disorder symptoms,anxiety test,natural remedies for depression,anxiety disorder treatment,natural remedies for anxiety,how to deal with… Continue reading →
Drug and Alcohol Rehabilitation: Cobicistat-Boosted Elvitegravir-Based Fixed-Dose Combination Antiretroviral Therapy for HIV Infection.
Cobicistat-boosted elvitegravir-based fixed-dose combination antiretroviral therapy for HIV infection.
Filed under: Drug and Alcohol Rehabilitation
Drugs Today (Barc). 2012 Dec; 48(12): 765-71
Temesgen Z
A fixed-dose co-formulated antiretroviral drug containing elvitegravir, a new integrase strand transfer inhibitor, boosted by a novel pharmacokinetic enhancer cobicistat, and further containing the nucleoside pair of tenofovir and emtricitabine was recently approved by the U.S. Food and Drug Administration as a single-tablet, once-a-day treatment of HIV-1 infection in antiretroviral therapy-naive adults. This drug was found to be noninferior to two currently preferred antiretroviral regimens in clinical practice in two large, 48-week, phase III studies. Renal adverse effects limit its use to those with creatinine clearance > 70 mL/min; its considerable drug interaction potential requires care and attention when used. Nevertheless, the… Continue reading →
Recent Posts
- What Is the Difference Between Christian Drug Rehab and Others?
- Sugar Free Diet? Are They Realistic Long Term, Permanently?
- What Worked Best for Long Term Drug Intervention for Teen With Pot?
- Morro Bay Young Adult Author Tackles Serious Issue
- Questions, Doubts Surround Ford's Whereabouts, Treatment
- Do Something About Hearing Loss During Better Hearing Month